PTU Final Exam-Complete questions and correct verified answers (detailed answers) already graded A+

PTU Final Exam-Complete questions and correct
verified answers (detailed answers) already graded
A+



Patient Package Insert (PPI)


Manufacturer's patient product information included with the
product package.


Hatch-Waxman Act of 1984


promoted the manufacturing of generic drugs and new
medications

MedGuides


FDA-approved documents created to educate patients about how
to minimize harm from potentially dangerous drugs


Class I recall


Serious adverse effects on health or death

,Class II recall


temporary or reversible adverse effects


Class III recall


Unlikely to cause adverse health consequences


Market Withdrawal


permanent removal from the market, drug is harmful of unapproved


pharmacological alternative


same active ingredient, different dosage form/strength


therapeutic alternative


different active ingredient, same drug class



DAW 0


no preference, OK to substitute

, DAW 1


substitution not allowed by prescriber


DAW 2
substitution allowed, patient requested specific product




DAW 7


substitution not allowed; brand mandated by law


DAW 8


Substitution allowed; generic drug not available in marketplace


DAW 3


Substitution allowed; pharmacist-selected product dispensed


DAW 4


Substitution allowed - generic drug not in stock